| Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis N Huang, AV Pandey, V Agrawal, W Reardon, PD Lapunzina, D Mowat, ... The American Journal of Human Genetics 76 (5), 729-749, 2005 | 364 | 2005 |
| Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations N Huang, V Agrawal, KM Giacomini, WL Miller Proceedings of the National Academy of Sciences 105 (5), 1733-1738, 2008 | 246 | 2008 |
| A novel UV laser-induced visible blue radiation from protein crystals and aggregates: scattering artifacts or fluorescence transitions of peptide electrons delocalized through … A Shukla, S Mukherjee, S Sharma, V Agrawal, KV Radha Kishan, ... Archives of biochemistry and biophysics 428 (2), 144-153, 2004 | 164 | 2004 |
| Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19 V Agrawal, N Huang, WL Miller Pharmacogenetics and genomics 18 (7), 569-576, 2008 | 142 | 2008 |
| Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. V Agrawal, JH Choi, KM Giacomini, WL Miller Pharmacogenetics and genomics 20 (10), 611-618, 2010 | 140 | 2010 |
| Consequences of POR mutations and polymorphisms WL Miller, V Agrawal, D Sandee, MK Tee, N Huang, JH Choi, K Morrissey, ... Molecular and cellular endocrinology 336 (1), 174-179, 2011 | 108 | 2011 |
| P450 oxidoreductase deficiency–a new form of congenital adrenal hyperplasia CE Flück, A Pandey, N Huang, V Agrawal, W Miller Karger Publishers 13, 67-81, 2008 | 104 | 2008 |
| Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency LG Gomes, N Huang, V Agrawal, BB Mendonca, TASS Bachega, ... The Journal of Clinical Endocrinology & Metabolism 94 (1), 89-95, 2009 | 93 | 2009 |
| Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro D Sandee, K Morrissey, V Agrawal, HK Tam, MA Kramer, TS Tracy, ... Pharmacogenetics and genomics 20 (11), 677-686, 2010 | 90 | 2010 |
| Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients T Sahakitrungruang, N Huang, MK Tee, V Agrawal, WE Russell, P Crock, ... The Journal of Clinical Endocrinology & Metabolism 94 (12), 4992-5000, 2009 | 88 | 2009 |
| Promiscuous binding nature of SH3 domains to their target proteins V Agrawal, KV Kishan Protein and peptide letters 9 (3), 185-193, 2002 | 79 | 2002 |
| OB-fold: growing bigger with functional consistency V Agrawal, KV Kishan Current Protein and Peptide Science 4 (3), 195-206, 2003 | 69 | 2003 |
| Genetic variation in human P450 oxidoreductase WL Miller, N Huang, V Agrawal, KM Giacomini Molecular and cellular endocrinology 300 (1), 180-184, 2009 | 65 | 2009 |
| The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency LG Gomes, N Huang, V Agrawal, BB Mendonca, TASS Bachega, ... The Journal of Clinical Endocrinology & Metabolism 93 (7), 2913-2916, 2008 | 59 | 2008 |
| Functional evolution of two subtly different (similar) folds V Agrawal, RKV Kishan BMC structural biology 1 (1), 5, 2001 | 57 | 2001 |
| Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9. 1, CYP2C9. 2, and CYP2C9. 3 M Subramanian, V Agrawal, D Sandee, HK Tam, WL Miller, TS Tracy Pharmacogenetics and genomics 22 (8), 590-597, 2012 | 55 | 2012 |
| Molecular Structure of d-Hydantoinase from< i> Bacillus</i> sp. AR9: Evidence for Mercury Inhibition KV Radha Kishan, RM Vohra, K Ganesan, V Agrawal, VM Sharma, ... Journal of molecular biology 347 (1), 95-105, 2005 | 39 | 2005 |
| SH3-like fold proteins are structurally conserved and functionally divergent KVR Kishan, V Agrawal Current Protein and Peptide Science 6 (2), 143-150, 2005 | 29 | 2005 |
| COVID‑19 pandemic: Understanding the emergence, pathogenesis and containment MK Parvez, RM Jagirdar, RS Purty, SK Venkata, V Agrawal, J Kumar, ... World Academy of Sciences Journal 2 (5), 1-1, 2020 | 19 | 2020 |
| Molecular insights into effector binding by DgoR, a GntR/FadR family transcriptional repressor of D‐galactonate metabolism in Escherichia coli G Arya, M Pal, M Sharma, B Singh, S Singh, V Agrawal, R Chaba Molecular Microbiology, 2020 | 14 | 2020 |
Walter L MillerDistinguished Professor of Pediatrics Emeritus, University of California, San FranciscoVerified email at ucsf.edu